IMC Chicago
CELG

IMC Chicago’s Celgene Corp CELG Stock Holding History

IMC Chicago’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-40,900
Closed -$4.06M – 884
2019
Q3 		$4.06M Sell
40,900
-18,800
-31% -$1.79M 0.01% 325
2019
Q2 		$5.52M Sell
59,700
-70,400
-54% -$6.69M 0.02% 264
2019
Q1 		$12.3M Buy
130,100
+19,800
+18% +$1.73M 0.04% 119
2018
Q4 		$7.07M Buy
+110,300
New +$8.14M 0.02% 149

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

IMC Chicago's CELG Position: Q2 2019 in Review

IMC Chicago sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 17,337 shares — an estimated $1.65M sold.

IMC Chicago first reported a position in CELG in Q1 2019 and held it in 1 quarter. The position peaked at $1.64M in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • IMC Chicago reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • IMC Chicago sold 17,337 Celgene Corp shares in Q2 2019, an estimated $1.65M.
  • IMC Chicago first reported a position in Celgene Corp in Q1 2019 and held it in 1 quarter.
  • IMC Chicago's Celgene Corp position peaked at $1.64M in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on IMC Chicago's 13F filing for Q2 2019, filed 15 Aug 2019.